Investors Asset Management of Georgia’s iShares Biotechnology ETF IBB Stock Holding History

Investors Asset Management of Georgia’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-120	Closed	-$14K	–	334
2022 Q3	$14K	Hold	120	–	–	0.01%	433
2022 Q2	$14K	Buy	+120	New	+$14.2K	0.01%	371

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $3.05B AUM 42.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CANY

Caxton Associates (New York) New York $3.18B AUM 54.49% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Investors Asset Management of Georgia's IBB Position: Q4 2022 in Review

Investors Asset Management of Georgia sold out of iShares Biotechnology ETF (IBB) in Q4 2022, closing a stake of 120 shares — an estimated $14K sold.

Investors Asset Management of Georgia first reported a position in IBB in Q2 2022 and held it in 2 quarters. The position peaked at $14K in Q3 2022. 903 funds tracked by Wall St. Rank hold IBB as of Q4 2022.

Investors Asset Management of Georgia reported no remaining iShares Biotechnology ETF position as of Q4 2022 after selling out during the quarter.
Investors Asset Management of Georgia sold 120 iShares Biotechnology ETF shares in Q4 2022, an estimated $14K.
Investors Asset Management of Georgia first reported a position in iShares Biotechnology ETF in Q2 2022 and held it in 2 quarters.
Investors Asset Management of Georgia's iShares Biotechnology ETF position peaked at $14K in Q3 2022.
903 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2022.

Based on Investors Asset Management of Georgia's 13F filing for Q4 2022, filed 2 Feb 2023.